ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3,1,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4,1,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
5,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
7,1,Sudden infant death syndrome,Death and sudden death,Fatal outcomes,Genrl,Y
8,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8,2,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
9,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
10,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
10,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
11,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
11,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
11,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
11,5,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
12,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
12,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
13,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
13,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
14,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
14,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
14,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
15,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
15,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
15,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
16,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
16,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
16,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
16,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
16,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
16,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
16,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
16,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
17,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
17,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
18,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
19,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
19,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
19,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
20,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
20,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
21,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
21,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
21,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
